Prenetics accelerates the development of healthy consumers' businesses and strategically reserves Bitcoin to help achieve growth in 2025

Prenetics, a genomics-driven health science company, is making its mark in a $5 trillion health market through its high-end supplement brand IM8 and Bitcoin funding strategies. Co-founded by David Beckham, IM8 has achieved over $50 million in annual recurring revenue in six months serving 60,000 customers. In the first quarter of 2025, IM8 had revenue of $5.7 million and was expected to reach $8.5 million in the second quarter. Prenetics raised its full-year revenue forecast to $80 million to $100 million. In addition, the company invested $20 million in March 2025 to hedge macroeconomic uncertainty by diversifying investments in digital assets.